Neuronet - Efficiently Networking European Neurodegeneration Research

          Newsletter 3 - March 10, 2020

Welcome to the third
issue of the Neuronet newsletter! 

This third newsletter issue provides you with up-to-date insights on the Innovative Medicines Initiative’s (IMI) research efforts to tackle challenges in neurodegeneration.

At the beginning of February we held a very engaging Lunch Debate chaired by Luxembourgish MEP Christophe Hansen and we would like to extend our gratitude for the excellent moderation. The debate focussed on the Innovative Medicines Initiative’s work to advance Alzheimer’s research. An “asset map” depicting the many tangible results from IMI projects will soon be available from the NEURONET web site.

We also have some exciting news for science communication enthusiasts. Alzheimer Europe is looking to recruit a new Project Communications Officer to lead the communication activities of Neuronet.

As always, this newsletter also provides you with updates on progress and achievements from the IMI neurodegeneration research projects.

Last but not least, we'd like to highlight that this issue also features a spotlight on early-career investigators. We spoke to Alpha Tom Kodamullil who told us about her work on the AETIONOMY project.

Happy reading !
Carlos Díaz
Neuronet Project Coordinator
Research Management Partners
Lennert Steukers
Neuronet Project Leader
Associate Director,
Clinical Scientist, Janssen Pharmaceutica NV



Spotlight on early-career investigators: a Neuronet interview with Alpha Tom Kodamullil

Thanks to new technological advances in computing, the fields of data science and bioinformatics are now coming to the fore, enabling researchers to advance our fundamental understanding of disease by mining complex datasets.  In this early-career investigator interview, we talk to Alpha Tom Kodamullil, who has recently been promoted to a Group Leader position at the Fraunhofer Institute for Algorithms and Scientific Computing (SCAI).
Read more

Neuronet and Alzheimer Europe team up for European Parliament Lunch Debate on the Innovative Medicines Initiative’s work to advance Alzheimer’s research

On 18 February, Alzheimer Europe held its first lunch debate of 2020. The debate was entitled “The Innovative Medicines Initiative (IMI): Advancing Alzheimer’s research through public-private partnerships” and was organised in partnership between Alzheimer Europe and the Neuronet Coordination and Support Action
Read more

AMYPAD Prognostic and Natural History Study reaches milestone of 500 research participants

The members of the Amyloid Imaging to Prevent Alzheimer’s Disease initiative reached a significant milestone with the enrolment of the 500th research participant in its Prognostic and Natural History Study (PNHS).
Read more

Neuronet holds successful third Scientific Coordination Board meeting in Madrid

On 28 January (Madrid, Spain), Neuronet convened the third meeting of its Scientific Coordination Board, welcoming its latest new member Jochen Prehn from the PD-MitoQUANT Consortium.
Read more

Job Opportunity


Alzheimer Europe is looking to recruit a new Project Communications Officer

Alzheimer Europe is looking to immediately fill the following Luxembourg-based position: 1 Project Communications Officer (m/f) (Full time), on a permanent basis to lead the communication activities of Neuronet.
Read more

Neuronet project newsletters

Amyloid imaging to prevent Alzheimer's disease Newsletter
February 2020 (AMYPAD)

AMYPAD looks back to this time last year with a view to highlighting the tremendous progress the AMYPAD teams have made since then.
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease Newsletter
February 2020 (PD-MitoQUANT)

Learning more about the role of mitochondrial dysfunction in Parkinson’s to help develop better therapies.
European Quality In Preclinical Data Newsletter
December 2019 (EQIPD)

This issue introduces videos about the project, features highlights from conferences & marks the launch of the second beta testing phase of EQIPDs new quality system.
European Prevention of Alzheimer's Dementia Newsletter
February 2020 (EPAD)

Find out about the highlights & achievements of 2019, and read about project insights in two interviews with project partners.

What we are talking about


Our programme is well represented on Twitter with updates from 13 projects. Follow us to stay ahead on news about European neurodegeneration research. We also collaborated on a campaign on social media focussing on on why we do what we do. Check out the hashtag #WeAreNeuronet
Twitter feed


This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any related content solely reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

          Newsletter 3 - March 10, 2020

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
NEURONET project · 14, rue Dicks · Luxembourg 1417 · Luxembourg

Email Marketing Powered by Mailchimp